|Bid||0.00 x 800|
|Ask||0.00 x 900|
|Day's Range||109.63 - 110.56|
|52 Week Range||86.16 - 128.54|
|Beta (5Y Monthly)||0.68|
|PE Ratio (TTM)||34.62|
|Earnings Date||Jul. 14, 2021 - Jul. 19, 2021|
|Forward Dividend & Yield||1.80 (1.63%)|
|Ex-Dividend Date||Jul. 14, 2021|
|1y Target Est||125.81|
In the latest trading session, Abbott (ABT) closed at $110.48, marking a +0.52% move from the previous day.
(Bloomberg) -- When Abbott Laboratories chief Miles White cashed out $32 million of stock and options in 2019, shareholders had reason to shrug it off. Online regulatory filings said the sales were part of a “previously adopted plan” -- a sign they weren’t based on any current inside information.It turns out, the disposals that Monday had been set up the previous Friday. To learn that detail, investors would have to track down the plan he filed with the Securities and Exchange Commission by trav
COVID-19 testing ain't what it used to be. In this Motley Fool Live video recorded on June 2, Motley Fool contributors Keith Speights and Brian Orelli talk about what investors should make of Abbott's reduced guidance. Keith Speights: Abbott, ticker there is ABT, had some other news that wasn't so good.